ES2721270T3 - Composiciones de profármaco de aripiprazol - Google Patents

Composiciones de profármaco de aripiprazol Download PDF

Info

Publication number
ES2721270T3
ES2721270T3 ES15750750T ES15750750T ES2721270T3 ES 2721270 T3 ES2721270 T3 ES 2721270T3 ES 15750750 T ES15750750 T ES 15750750T ES 15750750 T ES15750750 T ES 15750750T ES 2721270 T3 ES2721270 T3 ES 2721270T3
Authority
ES
Spain
Prior art keywords
aripiprazole prodrug
surface stabilizer
aripiprazole
particles
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15750750T
Other languages
English (en)
Other versions
ES2721270T5 (es
Inventor
Philip Cresswell
Magali Hickey
Elaine Liversidge
David Manser
Michael Palmieri Jr
Sara Montminy Paquette
Kristopher Perkin
Greg Smith
Brian Steinberg
Ryan Turncliff
Tarek Zeidan
Ethan P Cash
Marjie L Hard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alkermes Pharma Ireland Ltd
Original Assignee
Alkermes Pharma Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkermes Pharma Ireland Ltd filed Critical Alkermes Pharma Ireland Ltd
Priority claimed from PCT/EP2015/068872 external-priority patent/WO2016026822A1/en
Application granted granted Critical
Publication of ES2721270T3 publication Critical patent/ES2721270T3/es
Publication of ES2721270T5 publication Critical patent/ES2721270T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición que comprende: (a) una población de partículas de un profármaco de aripiprazol que tiene un tamaño de partícula basado en volumen (Dv50) de entre 50 y 700 nm según lo determinado mediante técnicas de dispersión de la luz; (b) al menos un estabilizador superficial que comprende un componente adsorbido que se adsorbe sobre la superficie de las partículas del profármaco de aripiprazol y un componente libre disponible para la solubilización del profármaco de aripiprazol, en la que la proporción en peso del profármaco de aripiprazol con respecto al estabilizador superficial está en el intervalo de 17:1 a 26:1, y en la que el profármaco de aripiprazol tiene la fórmula:**Fórmula** en la que n es cero o un número entero inferior a 20, en la que el al menos un estabilizador superficial se selecciona del grupo que consiste en carboximetilcelulosa y ésteres de ácidos grasos de polioxietilensorbitán.
ES15750750T 2014-08-18 2015-08-17 Composiciones de profármaco de aripiprazol Active ES2721270T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462038665P 2014-08-18 2014-08-18
EP14181328 2014-08-18
PCT/EP2015/068872 WO2016026822A1 (en) 2014-08-18 2015-08-17 Aripiprazole prodrug compositions

Publications (2)

Publication Number Publication Date
ES2721270T3 true ES2721270T3 (es) 2019-07-30
ES2721270T5 ES2721270T5 (es) 2022-07-21

Family

ID=53872058

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15750750T Active ES2721270T5 (es) 2014-08-18 2015-08-17 Composiciones de profármaco de aripiprazol

Country Status (9)

Country Link
JP (2) JP6826167B2 (es)
CY (1) CY1121594T1 (es)
DK (1) DK3182958T4 (es)
ES (1) ES2721270T5 (es)
HR (1) HRP20190642T2 (es)
HU (1) HUE043169T2 (es)
LT (2) LT3182958T (es)
PT (1) PT3182958T (es)
TR (1) TR201905694T4 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3182958T (lt) * 2014-08-18 2019-06-25 Alkermes Pharma Ireland Limited Aripiprazolo provaisto kompozicijos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3182958T (lt) * 2014-08-18 2019-06-25 Alkermes Pharma Ireland Limited Aripiprazolo provaisto kompozicijos
AU2015306198B2 (en) * 2014-08-18 2021-02-25 Alkermes Pharma Ireland Limited Aripiprazole prodrug compositions

Also Published As

Publication number Publication date
RU2019134055A (ru) 2020-02-03
DK3182958T4 (da) 2022-07-04
ES2721270T5 (es) 2022-07-21
DK3182958T3 (da) 2019-05-06
HUE043169T2 (hu) 2019-08-28
JP7157830B2 (ja) 2022-10-20
HRP20190642T2 (hr) 2022-07-08
LT3182958T (lt) 2019-06-25
LT3508196T (lt) 2021-09-10
CY1121594T1 (el) 2020-05-29
HRP20190642T4 (hr) 2022-06-24
JP6826167B2 (ja) 2021-02-03
HRP20190642T1 (hr) 2019-05-31
TR201905694T4 (tr) 2019-05-21
PT3182958T (pt) 2019-05-23
JP2021059604A (ja) 2021-04-15
JP2020007316A (ja) 2020-01-16

Similar Documents

Publication Publication Date Title
AR127861A2 (es) Composición farmacéutica que comprende inhibidores del proteasoma peptídico y ciclodextrina
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
BR112016024357A2 (pt) composições de insulina de ação rápida
BR112017008720A2 (pt) métodos e composições relacionados a nanoveículos sintéticos com rapamicina em um estado supersaturado, estável
MY165124A (en) Semifluorinated alkane compositions
BR112015021923A2 (pt) composições de limpeza contendo uma polieteramina, um polímero removedor de sujeiras e uma carboximetil-celulose
BR112015032338A2 (pt) composições e artigos para cuidados pessoais
UA113440C2 (xx) Сполуки тетрагідропіразолопіримідину
BR112017009277A2 (pt) compostos de silicone
BR112015023321A2 (pt) dispersões submicrômetras substancialmente livres de surfactante e alimento com as mesmas
BR112016023676A2 (pt) pó de sinterização com baixa pressão
PE20151793A1 (es) Compuestos heterociclicos moduladores de la piruvato quinasa y composiciones que los contienen
PE20160605A1 (es) Formulaciones de inhibidores de la syk
CR20160499A (es) Composiciones estables de yodo no en complejo y métodos de uso
BR112015012841A2 (pt) composição imunogênica, vacina, e, uso de uma composição imunogênica
BR112015023387A2 (pt) composições lipídicas de racecodotril
BR112017002926A2 (pt) composições e método para aprimorar o perfil de liberação farmacocinético inicial in vivo
BR112016008502A2 (pt) Composição refrigerante
BR112015001728B8 (pt) composições de condicionador
UY35824A (es) Preparación farmacéutica y forma de su producción y uso
BR112014018094A2 (pt) composição de mistura contendo siloxanos amino-funcionais, partículas hidrofóbicas e silicones de elevado peso molecular e o seu uso para tratamento de couro
BR112015022940A2 (pt) composições líquidas de racecadotrila
CL2015002702A1 (es) Composiciones farmacéuticas micronizadas.
ES2721270T3 (es) Composiciones de profármaco de aripiprazol
MX2022010827A (es) Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados.